scholarly article | Q13442814 |
P2093 | author name string | John Jeffery | |
David Rush | |||
Peter Nickerson | |||
Kiril Trpkov | |||
Kim Solez | |||
James Gough | |||
Rachel McKenna | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | reproducibility | Q1425625 |
P304 | page(s) | 1081-1084 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
P1476 | title | Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. | |
P478 | volume | 17 |
Q91281568 | A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study |
Q40082066 | A study of interobserver reproducibility of morphologic lesions of focal segmental glomerulosclerosis. |
Q34862535 | Advances of genomic science and systems biology in renal transplantation: a review |
Q92741684 | Assessment of active tubulointerstitial nephritis in non-scarred renal cortex improves prediction of renal outcomes in patients with IgA nephropathy |
Q38893693 | Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand? |
Q37636475 | Borderline rejection after renal transplantation--to treat or not to treat |
Q34945314 | Calcineurin inhibitor nephrotoxicity |
Q36240051 | Chronic renal allograft dysfunction |
Q57053812 | Comparison of native and transplant kidney biopsies: diagnostic yield and complications |
Q46908569 | Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function |
Q39676693 | Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. |
Q38843499 | Current status of pediatric renal transplant pathology |
Q46937132 | Do we have to treat subclinical rejections in early protocol renal allograft biopsies? |
Q63916008 | Functional Genomic Analysis of Peripheral Blood During Early Acute Renal Allograft Rejection |
Q81395033 | Functionally significant renal allograft rejection is defined by transcriptional criteria |
Q81553565 | Getting out of flatland: into the third dimension of microarrays |
Q53064008 | Histological assessment of pre-transplant kidney biopsies is reproducible and representative. |
Q91600536 | Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients |
Q91301296 | Impact of Subclinical Rejection on Kidney Graft Function |
Q36849398 | Impact of specimen adequacy on the assessment of renal allograft biopsy specimens. |
Q53301318 | International variation in histologic grading is large, and persistent feedback does not improve reproducibility. |
Q48160896 | Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study. |
Q39936865 | KDIGO clinical practice guideline for the care of kidney transplant recipients |
Q60194443 | Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co‐immunostain: a retrospective study on reproducibility and clinical/prognostic correlates |
Q91621909 | Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials |
Q34021746 | New computerized color image analysis for the quantification of interstitial fibrosis in renal transplantation. |
Q47588349 | Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine |
Q80796865 | Opening words for CJASN |
Q40289674 | Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles |
Q91132611 | Predicting outcome in acute interstitial nephritis: a case-series examining the importance of histological parameters |
Q91216747 | Proteomics in Kidney Allograft Transplantation-Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection |
Q36029862 | Protocol biopsies after kidney transplantation |
Q36863467 | Protocol biopsies in renal transplantation: prognostic value of structural monitoring |
Q46937125 | Quantification of interstitial fibrosis by image analysis on routine renal biopsy 1 year after transplantation in patients managed by C2 monitoring of cyclosporine microemulsion. |
Q50651840 | Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine. |
Q47811161 | Re-evaluation of glomerulitis using occlusion criteria based on the Banff 2013 revision: a retrospective study |
Q44752668 | Reliability of whole slide images as a diagnostic modality for renal allograft biopsies. |
Q36929501 | Renal transplant rejection markers |
Q52979594 | Reproducibility of the Banff classification in subclinical kidney transplant rejection. |
Q53003709 | Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. |
Q36937329 | SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. |
Q38699017 | Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants. |
Q37247288 | The significance of subclinical rejection |
Q36517003 | The significance of subclinical rejection and the value of protocol biopsies |
Q43507137 | Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients |
Q36950868 | To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? |
Q84050785 | Tools to identify organ rejection and immune quiescence for biological understanding and personalized medical care |
Q38645390 | Zero-Time Renal Transplant Biopsies: A Comprehensive Review. |
Q81784337 | [Interest of screening biopsies in renal transplantation] |
Q50576077 | [Recent approaches of quantification of interstitial fibrosis in renal transplantation]. |
Search more.